Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. (Q50081492)
Jump to navigation
Jump to search
scientific article published on 17 October 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. |
scientific article published on 17 October 2017 |
Statements
1 reference
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. (English)
1 reference
Masatoshi Kudo
1 reference
Takashi Kumada
1 reference
Hidenori Toyoda
1 reference
Toshifumi Tada
1 reference
Masashi Hirooka
1 reference
Toru Ishikawa
1 reference
Noritomo Shimada
1 reference
Hironori Ochi
1 reference
Yohei Koizumi
1 reference
Kojiro Michitaka
1 reference
Atsushi Hiraoka
1 reference
Michitaka Imai
1 reference
Yoichi Hiasa
1 reference
Koji Joko
1 reference
Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics)
1 reference
Akihiro Deguchi
1 reference
Kunihiko Tsuji
1 reference
17 October 2017
1 reference
1 reference
35
1 reference
6
1 reference
602-610
1 reference
Identifiers
1 reference
1 reference